L. J. Wei

Follow

Generating author description...

All published works
Action Title Year Authors
+ PDF Chat Using a Clinically Interpretable End Point Composed of Multiple Outcomes to Evaluate Totality of Treatment Effect in Comparative Oncology Studies 2023 Xiaofei Wang
Zachary R. McCaw
LĂŒ Tian
Thomas E. Stinchcombe
Everett E. Vokes
Ethan B. Ludmir
L. J. Wei
+ Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event—Moving Beyond C Statistic 2023 Xuan Wang
Brian Claggett
LĂŒ Tian
Marcus VinĂ­cius BolĂ­var Malachias
Marc A. Pfeffer
L. J. Wei
+ Handling Informative Premature Treatment or Study Discontinuation for Assessing Between-Group Differences in a Comparative Oncology Trial 2022 Bo Huang
Ryan Sun
Brian Claggett
LĂŒ Tian
Ethan B. Ludmir
L. J. Wei
+ PDF Chat Quantifying Treatment Effects in Trials with Multiple Event-Time Outcomes 2022 Brian Claggett
Zachary R. McCaw
LĂŒ Tian
John J.V. McMurray
Pardeep S. Jhund
Hajime Uno
Marc A. Pfeffer
Scott D. Solomon
L. J. Wei
+ Robust Alternatives to ANCOVA for Estimating the Treatment Effect via a Randomized Comparative Study 2022 Fei Jiang
LĂŒ Tian
Haoda Fu
Takahiro Hasegawa
L. J. Wei
+ Practical Recommendations on Quantifying and Interpreting Treatment Effects in the Presence of Terminal Competing Risks 2021 Zachary R. McCaw
Brian Claggett
LĂŒ Tian
Scott D. Solomon
OtĂĄvio Berwanger
Marc A. Pfeffer
L. J. Wei
+ Choosing clinically interpretable summary measures and robust analytic procedures for quantifying the treatment difference in comparative clinical studies 2021 Zachary R. McCaw
LĂŒ Tian
Jiawei Wei
Brian Claggett
Frank Bretz
Garrett M. Fitzmaurice
L. J. Wei
+ Robust Alternatives to ANCOVA for Estimating the Treatment Effect via a Randomized Comparative Study 2021 Fei Jiang
LĂŒ Tian
Haoda Fu
Takahiro Hasegawa
L. J. Wei
+ Restricted mean survival time analysis in heart failure clinical trials 2020 Carlotta Perego
Marco Sbolli
Claudia Specchia
Chiara Oriecuia
Giulia Peveri
Mona Fiuzat
Cathal O’Connor
Marco Metra
L. J. Wei
Mitchell A. Psotka
+ Appropriate Analysis of Duration of Response Data in Cancer Trials 2020 Zachary R. McCaw
LĂŒ Tian
L. J. Wei
+ Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation 2020 Carlotta Perego
Marco Sbolli
Claudia Specchia
Mona Fiuzat
Zachary R. McCaw
Marco Metra
Chiara Oriecuia
Giulia Peveri
L. J. Wei
Christopher M. O’Connor
+ Restricted Mean Survival Time for Analysis and Interpretation of Clinical Trials for Heart Failure Devices 2020 Carlotta Perego
Marco Sbolli
Claudia Specchia
Chiara Oriecuia
Giulia Peveri
Mona Fiuzat
Christopher M. O’Connor
Marco Metra
L. J. Wei
Mitchell A. Psotka
+ Analysis of Response Data for Assessing Treatment Effects in Comparative Clinical Studies 2020 Bo Huang
LĂŒ Tian
Zachary R. McCaw
Xiaodong Luo
Enayet Talukder
Mace L. Rothenberg
Wanling Xie
Toni K. Choueiri
Dae Hyun Kim
L. J. Wei
+ Using Confidence Intervals to Quantify Statistical and Clinical Evidence for the Treatment Effect in a Comparative Study—Moving Beyond <i>P</i> Values 2019 Dustin J. Rabideau
Dae Hyun Kim
L. J. Wei
+ Assessing Clinical Equivalence in Oncology Biosimilar Trials With Time-to-Event Outcomes 2019 Hajime Uno
Deborah Schrag
Dae Hyun Kim
Dejun Tang
LĂŒ Tian
Hope S. Rugo
L. J. Wei
+ Restricted mean survival time for the analysis of cardiovascular outcome trials assessing non-inferiority: Case studies from antihyperglycemic drug development 2019 David H. Manner
Chakib Battioui
Stefan Hantel
B. Nhi Beasley
L. J. Wei
Mary Jane Geiger
J. Rick Turner
Markus Abt
+ Unifying Design and Analysis for Superiority and Noninferiority Trials With Appropriate End Point 2019 Brian Claggett
Hajime Uno
L. J. Wei
+ PDF Chat Response by Claggett et al to Letter Regarding Article, “Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical Trials” 2019 Brian Claggett
Stuart J. Pocock
L. J. Wei
Marc A. Pfeffer
John J.V. McMurray
Scott D. Solomon
+ Robust Alternatives to ANCOVA for Estimating the Treatment Effect via a Randomized Comparative Study 2019 Fei Jiang
LĂŒ Tian
Haoda Fu
Takahiro Hasegawa
L. J. Wei
+ PDF Chat Robust Alternatives to ANCOVA for Estimating the Treatment Effect via a Randomized Comparative Study 2018 Fei Jiang
LĂŒ Tian
Haoda Fu
Takahiro Hasegawa
L. J. Wei
+ PDF Chat Applying Evidence-Based Medicine to Shared Decision Making: Value of Restricted MeanSurvival Time 2018 Zachary R. McCaw
Ariela R. Orkaby
L. J. Wei
Dae Hyun Kim
Michael W. Rich
+ PDF Chat Quantifying the totality of treatment effect with multiple event‐time observations in the presence of a terminal event from a comparative clinical study 2018 Brian Claggett
LĂŒ Tian
Haoda Fu
Scott D. Solomon
L. J. Wei
+ Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical Trials 2018 Brian Claggett
Stuart J. Pocock
L. J. Wei
Marc A. Pfeffer
John J.V. McMurray
Scott D. Solomon
+ Evaluating Noninferiority With Clinically Interpretable Statistics for the PROSELICA Study to Assess Treatment Efficacy of a Reduced Dose of Cabazitaxel for Treating Metastatic Prostate Cancer 2018 Miki Horiguchi
Hajime Uno
L. J. Wei
+ PDF Chat Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio 2017 Kyongsun Pak
Hajime Uno
Dae Hyun Kim
LĂŒ Tian
Robert C. Kane
Masahiro Takeuchi
Haoda Fu
Brian Claggett
L. J. Wei
+ Efficiency of Two Sample Tests via the Restricted Mean Survival Time for Analyzing Event Time Observations 2017 LĂŒ Tian
Haoda Fu
Stephen J. Ruberg
Hajime Uno
L. J. Wei
+ PDF Chat Optimal stratification in outcome prediction using baseline information 2016 Florence H. Yong
LĂŒ Tian
Sheng Yu
Tianxi Cai
L. J. Wei
+ PDF Chat On the Restricted Mean Survival Time Curve in Survival Analysis 2015 Lihui Zhao
Brian Claggett
LĂŒ Tian
Hajime Uno
Marc A. Pfeffer
Scott D. Solomon
Lorenzo Trippa
L. J. Wei
+ PDF Chat A versatile test for equality of two survival functions based on weighted differences of Kaplan–Meier curves 2015 Hajime Uno
LĂŒ Tian
Brian Claggett
L. J. Wei
+ PDF Chat Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies 2015 Hajime Uno
Janet Wittes
Haoda Fu
Scott D. Solomon
Brian Claggett
LĂŒ Tian
Tianxi Cai
Marc A. Pfeffer
Scott Evans
L. J. Wei
+ Gehan–Gilbert Test 2014 L. J. Wei
E. A. Gehan
+ Friedman's URN Model 2014 L. J. Wei
+ <scp>P</scp> olya's Urn Model 2014 L. J. Wei
+ Wei‐Lin‐Weissfeld Method for Multiple Times to Events 2014 James Signorovitch
L. J. Wei
+ Selection Bias 2014 L. J. Wei
Charles D. Cowan
+ PDF Chat Effectively Selecting a Target Population for a Future Comparative Study 2013 Lihui Zhao
LĂŒ Tian
Tianxi Cai
Brian Claggett
L. J. Wei
+ The Highest Confidence Density Region and Its Usage for Joint Inferences about Constrained Parameters 2010 LĂŒ Tian
Rui Wang
Tianxi Cai
L. J. Wei
+ PDF Chat Nonparametric inference procedure for percentiles of the random effects distribution in meta-analysis 2010 Rui Wang
LĂŒ Tian
Tianxi Cai
L. J. Wei
+ PDF Chat Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction 2008 LĂŒ Tian
Tianrun Cai
Michael Pfeffer
Nikita Piankov
Pierre‐Yves CrĂ©mieux
L. J. Wei
+ PDF Chat Identifying Subjects Who Benefit from Additional Information for Better Prediction of the Outcome Variables 2008 LĂŒ Tian
Tianxi Cai
L. J. Wei
+ Wei‐Lin‐Weissfeld Method for Multiple Times to Events 2008 James Signorovitch
L. J. Wei
+ The Highest Confidence Density Region and Its Usage for Inferences about the Survival Function with Censored Data 2008 LĂŒ Tian
Rui Wang
Tianxi Cai
L. J. Wei
+ PDF Chat Predicting future responses based on possibly mis-specified working models 2007 Tommaso Cai
LĂŒ Tian
Scott D. Solomon
L. J. Wei
+ Implementation of Estimating Function-Based Inference Procedures With Markov Chain Monte Carlo Samplers 2007 LĂŒ Tian
Jun S. Liu
L. J. Wei
+ Effectively Combining Independent 2 x 2 Tables for Valid Inferences in Meta Analysis with all Available Data but no Artificial Continuity Corrections for Studies with Zero Events and its Application to the Analysis of Rosiglitazone's Cardiovascular Disease Related Event Data 2007 LĂŒ Tian
Tianxi Cai
Nikita Piankov
Pierre‐Yves CrĂ©mieux
L. J. Wei
+ <scp>G</scp>ehan–<scp>G</scp>ilbert Test 2005 L. J. Wei
E. A. Gehan
+ Selection Bias 2005 L. J. Wei
Charles D. Cowan
+ Play‐The‐Winner Rules 2005 L. J. Wei
David P. Byar
+ PDF Chat The optimal confidence region for a random parameter 2005 Hajime Uno
LĂŒ Tian
L. J. Wei
+ <scp>P</scp> olya's Urn Model 2005 L. J. Wei
+ Statistical Inferences Based On Non-Smooth Estimating Functions 2004 LĂŒ Tian
Jun Liu
Mary Zhao
L. J. Wei
+ Statistical Inference for Infinite Dimensional Parameters Via Asymptotically Pivotal Estimating Functions 2004 Meredith A. Goldwasser
LĂŒ Tian
L. J. Wei
+ Accelerated failure time models for counting processes 1998 D. Y. Lin
L. J. Wei
Zhiliang Ying
+ Analysis of incomplete repeated measurements with dependent censoring times 1998 Q. Yao
L. J. Wei
Joseph W. Hogan
+ AN OVERVIEW OF STATISTICAL METHODS FOR MULTIPLE FAILURE TIME DATA IN CLINICAL TRIALS 1997 L. J. Wei
David V. Glidden
+ Predicting Survival Probabilities With Semiparametric Transformation Models 1997 Sen Cheng
L. J. Wei
Z. Ying
+ A Resampling Method Based on Pivotal Estimating Functions 1994 M. I. Parzen
L. J. Wei
Z. Ying
+ Linear Regression Analysis for Multivariate Failure Time Observations 1992 Ji Lin
L. J. Wei
+ Linear Regression Analysis Based on Buckley-James Estimating Equation 1992 Lin Js
L. J. Wei
+ PDF Chat [A Survey of Exact Inference for Contingency Tables]: Comment 1992 Dan Lin
L. J. Wei
+ Cox-Type Regression Analysis for Large Numbers of Small Groups of Correlated Failure Time Observations 1992 Eric W. Lee
L. J. Wei
David A. Amato
Sue Leurgans
+ Exact Statistical Inference for Group Sequential Trials 1991 D. Y. Lin
L. J. Wei
David L. DeMets
+ Repeated Confidence Intervals for a Scale Change in a Sequential Survival Study 1991 D. Y. Lin
L. J. Wei
+ PDF Chat Permutation tests following restricted randomization procedures 1990 John M. Lachin
John P. Matts
L. J. Wei
+ Interim analyses with repeated measurements in a sequential clinical trial 1990 L. J. Wei
John Q. Su
John M. Lachin
+ Interval estimation with restricted randomization rules 1989 L. J. Wei
R. T. Smythe
Cyrus R. Mehta
+ PDF Chat Randomization in clinical trials: Conclusions and recommendations 1988 John M. Lachin
John P. Matts
L. J. Wei
+ PDF Chat Properties of the urn randomization in clinical trials 1988 L. J. Wei
John M. Lachin
+ Constructing exact significance tests with restricted randomization rules 1988 Cyrus R. Mehta
Nitin R. Patel
L. J. Wei
+ A One‐Sided Rank Test for Multivariate Censored Data 1987 L. J. Wei
Matthew Knuiman
+ PDF Chat $K$-Treatment Comparisons with Restricted Randomization Rules in Clinical Trials 1986 L. J. Wei
R. T. Smythe
Richard L. Smith
+ Combining Dependent Tests with Incomplete Repeated Measurements 1985 L. J. Wei
Wayne E. Johnson
+ Two-Sample Asymptotically Distribution-Free Tests for Incomplete Multivariate Observations 1984 L. J. Wei
John M. Lachin
+ Nonparametric Estimation for a Scale-Change with Censored Observations 1983 L. J. Wei
Mitchell H. Gail
+ TESTS FOR INDEPENDENCE IN THE PRESENCE OF MISSING VALUES 1983 L. J. Wei
+ Significance tests with restricted randomization design 1983 R. T. Smythe
L. J. Wei
+ Two-Sample Repeated Significance Tests Based on the Modified Wilcoxon Statistic 1982 Eric Slud
L. J. Wei
+ A bayesian nonparametric estimator of survival probability assuming increasing failure rate 1981 W. J. Padgett
L. J. Wei
+ A Generalized Gehan and Gilbert Test for Paired Observations that are Subject to Arbitrary Right Censorship 1980 L. J. Wei
+ A Generalized Gehan and Gilbert Test for Paired Observations that are Subject to Arbitrary Right Censorship 1980 L. J. Wei
+ Maximum Likelihood Estimation of a Distribution Function with Increasing Failure Rate Based on Censored Observations 1980 W. J. Padgett
L. J. Wei
+ A Test of the Parameter of the Exponential Distribution in the Type I Censoring Case 1980 John D. Spurrier
L. J. Wei
+ Maximum likelihood estimation of a distribution function with increasing failure rate based on censored observations 1980 W. J. Padgett
L. J. Wei
+ Interval Estimation after Sequential Testing for the Mean of the Exponential Distribution in the Large Sample Case. 1979 W. J. Padgett
L. J. Wei
+ PDF Chat The Generalized Polya's Urn Design for Sequential Medical Trials 1979 L. J. Wei
+ Estimation for the three-parameter inverse gaussian distribution 1979 W. J. Padgett
L. J. Wei
+ The Randomized Play-the-Winner Rule in Medical Trials 1978 L. J. Wei
S. D. Durham
+ The Randomized Play-the-Winner Rule in Medical Trials 1978 L. J. Wei
S. D. Durham
+ An Application of an Urn Model to the Design of Sequential Controlled Clinical Trials 1978 L. J. Wei
+ An Application of an Urn Model to the Design of Sequential Controlled Clinical Trials 1978 L. J. Wei
+ Bayesian Lower Bounds on Reliability for the Lognormal Model 1978 W. J. Padgett
L. J. Wei
+ PDF Chat The Adaptive Biased Coin Design for Sequential Experiments 1978 L. J. Wei
+ A class of treatment assignment rules for sequential experiments 1978 L. J. Wei
+ On the random allocation design for the control of selection bias in sequential experiments 1978 L. J. Wei
+ A Class of Designs for Sequential Clinical Trials 1977 L. J. Wei
+ A Class of Designs for Sequential Clinical Trials 1977 L. J. Wei
+ Bayes estimation of reliability for the two-parameter lognormal distribution 1977 W. J. Padgett
L. J. Wei
Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ A Class of Designs for Sequential Clinical Trials 1977 L. J. Wei
13
+ Forcing a sequential experiment to be balanced 1971 Bradley Efron
13
+ PDF Chat Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis 2014 Hajime Uno
Brian Claggett
LĂŒ Tian
Eisuke Inoue
Paul Gallo
Toshio Miyata
Deborah Schrag
Masahiro Takeuchi
Yoshiaki Uyama
Lihui Zhao
13
+ PDF Chat The Adaptive Biased Coin Design for Sequential Experiments 1978 L. J. Wei
10
+ Regression Analysis of Multivariate Incomplete Failure Time Data by Modeling Marginal Distributions 1989 L. J. Wei
D. Y. Lin
Lisa A. Weissfeld
9
+ The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt 2011 Patrick Royston
Mahesh Parmar
9
+ PDF Chat Design for the Control of Selection Bias 1957 David Blackwell
J. L. Hodges
9
+ Linear rank tests with right censored data 1978 Ross L. Prentice
8
+ PDF Chat Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves 2012 Patricia Guyot
A. E. Ades
Mario JNM Ouwens
Nicky J. Welton
8
+ PDF Chat Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies 2015 Hajime Uno
Janet Wittes
Haoda Fu
Scott D. Solomon
Brian Claggett
LĂŒ Tian
Tianxi Cai
Marc A. Pfeffer
Scott Evans
L. J. Wei
8
+ PDF Chat Predicting the restricted mean event time with the subject's baseline covariates in survival analysis 2013 LĂŒ Tian
Lihui Zhao
L. J. Wei
8
+ Misspecified proportional hazard models 1986 C. A. Struthers
John D. Kalbfleisch
7
+ The Robust Inference for the Cox Proportional Hazards Model 1989 D. Y. Lin
L. J. Wei
7
+ The use of random allocation for the control of selection bias 1969 Stephen M. Stigler
7
+ On distribution-free tests for equality of survival distributions 1977 Robert E. Tarone
James S. Ware
7
+ PDF Chat Counting Processes and Survival Analysis. 1992 Dorota M. Dabrowska
Thomas R. Fleming
David P. Harrington
7
+ Linear regression analysis of censored survival data based on rank tests 1990 L. J. Wei
Z. Ying
D. Y. Lin
6
+ PDF Chat Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio 2017 Kyongsun Pak
Hajime Uno
Dae Hyun Kim
LĂŒ Tian
Robert C. Kane
Masahiro Takeuchi
Haoda Fu
Brian Claggett
L. J. Wei
6
+ A generalized Wilcoxon test for comparing arbitrarily singly-censored samples 1965 E. A. Gehan
6
+ PDF Chat Bernard Friedman's Urn 1965 David A. Freedman
6
+ A resampling method based on pivotal estimating functions 1994 Michael Parzen
L. J. Wei
Z. Ying
6
+ PDF Chat Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome 2013 Patrick Royston
Mahesh Parmar
6
+ Nonparametrics: Statistical Methods Based on Ranks 1979 Mitchell J. Mergenthaler
E. L. Lehmann
5
+ Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials? 2016 Roger A’Hern
5
+ Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial 1975 Stuart J. Pocock
Richard Simon
5
+ Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials 2016 Ludovic Trinquart
Justine Jacot
Sarah C. Conner
Raphaël Porcher
5
+ Cox's Regression Model for Counting Processes: A Large Sample Study 1982 P. Andersen
Richard D. Gill
5
+ Longitudinal data analysis using generalized linear models 1986 Kung‐Yee Liang
Scott L. Zeger
5
+ PDF Chat Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study 2012 Lihui Zhao
LĂŒ Tian
Hajime Uno
Scott D. Solomon
Marc A. Pfeffer
Jerald Schindler
Lee Jen Wei
5
+ A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship 1970 Norman E. Breslow
5
+ PDF Chat Embedding of Urn Schemes into Continuous Time Markov Branching Processes and Related Limit Theorems 1968 Krishna B. Athreya
Samuel Karlin
5
+ Linear regression with censored data 1979 Jonathan D. Buckley
Ian James
5
+ PDF Chat Estimating Regression Parameters Using Linear Rank Tests for Censored Data 1990 Anastasios A. Tsiatis
5
+ Sequential Treatment Allocation Using Biased Coin Designs 1984 Richard L. Smith
4
+ PDF Chat Using the Restricted Mean Survival Time Difference as an Alternative to the Hazard Ratio for Analyzing Clinical Cardiovascular Studies 2019 Zachary R. McCaw
Guosheng Yin
Lee‐Jen Wei
4
+ Nonparametrics: Statistical Methods Based on Ranks. 1976 Robert J. Beaver
E. L. Lehmann
4
+ PDF Chat The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials 2016 Julien PĂ©ron
Pascal Roy
Brice Ozenne
Laurent Roche
Marc Buyse
4
+ Bayesian Inference in Statistical Analysis. 1975 Joseph B. Kadane
George E. P. Box
George C. Tiao
4
+ On the regression analysis of multivariate failure time data 1981 Ross L. Prentice
Brandon Williams
Arthur V. Peterson
4
+ Nonparametric Estimation from Incomplete Observations 1992 Edward L. Kaplan
Paul Meier
4
+ Simultaneous Confidence Intervals for the Difference of Two Survival Functions 1997 Michael Parzen
L. J. Wei
Z. Ying
4
+ Restricted Mean Life with Covariates: Modification and Extension of a Useful Survival Analysis Method 1998 David M. Zucker
4
+ Restricted Randomization Designs in Clinical Trials 1979 Richard Simon
4
+ Two-Sample Repeated Significance Tests Based on the Modified Wilcoxon Statistic 1982 Eric Slud
L. J. Wei
4
+ On the random allocation design for the control of selection bias in sequential experiments 1978 L. J. Wei
4
+ PDF Chat Semiparametric Regression for the Mean and Rate Functions of Recurrent Events 2000 D. Y. Lin
L. J. Wei
Ilsoon Yang
Z. Ying
4
+ A Generalized Gehan and Gilbert Test for Paired Observations that are Subject to Arbitrary Right Censorship 1980 L. J. Wei
4
+ PDF Chat The Generalized Polya's Urn Design for Sequential Medical Trials 1979 L. J. Wei
4
+ Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates 1984 Mitchell H. Gail
Sam Wieand
Steven Piantadosi
3
+ Properties of permuted-block randomization in clinical trials 1988 John P. Matts
John M. Lachin
3